Clinical Trial

Axitinib + Ipilimumab in Advanced Melanoma

Name: Axitinib + Ipilimumab in Advanced Melanoma — clinical trial record (NCT04996823)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Active, Not Recruiting Phase 2

View on ClinicalTrials.gov →

Summary

The goal of this clinical research study is to find out if taking axitinib with ipilimumab is effective in treating advanced melanoma.

Protocol Amendment History 1 change

critical Enrollment closed, study ongoing 2026-07-31

Trial Details

NCT Number	NCT04996823
Lead Sponsor	H. Lee Moffitt Cancer Center and Research Institute Collaborators: Pfizer
Conditions	Melanoma
Enrollment	24 participants
Start Date	2021-08-04
Primary Completion	2026-08-20 (estimated)
Study Completion	2027-03-29 (estimated)
Updated on ClinicalTrials.gov	2026-07-30